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Loca1 injections of corticosteroids are frequent1y used in the treatment of regiona1 pain， 
though the rationa1e for this is not clear. However， corticosteroids have been found to sup-
press ectopic discharges from experimenta1 neuromas and to have a short-1asting suppres-
sive effect on transmission in norma1 C-fibres. In this study， itwas investigated by record-
ing the action potentia1 of crayfish nerve that the inf1uence of a corticosteroid， betametha-
sone， on the increasing 10ca1 anesthetic action induced by Na-sa1icy1ate added to dibucaine， 
1idocaine and bupivacaine， respective1y. The resu1t showed that the action potentia1s disap-
peared in 13 minutes after treatment of 0.01% Na-sa1icy1ate added to 0.05% dibucaine 
which cou1d hard1y give anesthetic action， and were recovered to the norma1 1eve1s by 
washing 13 minutes after. Whi1e the onset time of anesthetic action was further shortened 
and recovery time was pro10nged besides， when the above two drugs were used as the 
combined solution with 0.3% betamethasone. But no a1teration of the action potentia1s was 
actually found in a mixture of 0.01 % Na-sa1icy1ate and 0.3% betamethasone. These tenden-
cies were a1so observed in the case of 2% 1idocaine or 0.3% bupivacaine though 0.05% 
dibucaine showed the prominent trend. The use of 10ca1 anesthetics combined with Na-
sa1icy1ate and betamethasone wou1d be promising in clinica1 practice for 10ca1 anesthesia as 
a nove1 mixed drug having rapid onset of anesthetic action and 10ng duration. 
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ルト液)4)は， NaCl 195 mM， KCl 5.4 mM， CaClz 
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Drugs Drug(%) 羽Tash(%) 
Harreve1d's solution 104.8土 15.3 91. 3 :! 8.4 
0.3% betamethasone 102.6 :! 5.5 99.3 :! 5.2 
0.01% Na-sa1icy1ate 104.6 :! 10.8 99.9 :! 14.5 
0.3% Na-sa1icy1ate 2.3 :! 2.6* 7.3::!:: 13.3* 
0.01 % Na-sa1icy1ate 
94.3 :! 4.6 91. 3 :! 6.4 + 0.3% betamethasone 
Drug(%):神経線維束に各試験液(Drugs)投与後30分の活動電位面積値， Wash(O/O):ハラベル
ト液洗浄後60分の活動電位面積値.表中の数値:各試験液を投与する前の活動電位面積値(コ



















































































D+ 0.3% BM 一---;コ一一










AP area after 30min 
(%) 













19.5 :t 5.2 
18.1 ごと 4.5 
















8.7 :t 1. 3* 
6.7土 2.5*
:t 2. 1 
13.2 ごと 2. 7 






0.6 :t 0.3% BM D 十
D: 0.05% dibucaine， BM: betamethasone， S:0.01 % Na-salicylate. Block time:各試験液投与後に神経
線維束の活動電位面積値が5%以下となるまでに要した時間， Half block time:活動電位面積備が50%に
減少するのに要した時間.AP area:各試験液投与後30分の活動電位面積値， AP areaの数値:各試験液
























D + 0.03% BM 
D + 0.1% BM 
D + 0.3% BM 
D + S 






20.0 :t 14.6 
Half Recovery time AP area after 30min 
(min) ( %) 
2.8 :t 1.3 85.2:t 17.5 
4.4土 2.4 79.0士 17.6
9.4 :t 7.0 76.4 :t 8.7 
7.7 こと 5.5 76. 7 ごと 20.0 
15.3 :t 3. 1キ 73.0 :t 13.7 
21. 4土 13.6* 82.0 土 24.2
D: 0.05% dibucaine， BM: betamethasone， S:0.01 % Na-salicy1ate.各試験液からの麻酔回復を示したも
ので， Recovery time:ハラベルト液洗浄で活動電位聞積が5%以上となるまでに要した時間， Half recov-
ery time:活動電位面積鍍が50%に回復するのに要した時間.AP area:洗浄後60分の活動電面積値， AP 
areaの数値:各試験液投与前の活動首位面積値(コントロール値)を100とした時の相対値(mean:! SD). 







た. Half b10ck timeを比較すると，ジブカイン
単独投与(21.4:t 6.0分)に対して0.1%ベタメタ





















































































































































AP area after 30min 
(%) 










14.6 ごと 5.7 
8. 2 :t 1. 9* 
7.4 :t 1. 7* 
L 
L + BM 
12.0 :t 4.2 
9.8:t 1.5 
L + S 
L + BM + S 
L: 2% lidocaine， BM: 0.3% betamethasone， S:0.01 % Na-salicylate.表中の表示:表2と同じ.
キ p< 0.05: 2% lidocaineに対して.
サリチル酸ナトリウム添加および三者混合の各試表5. リド力インにベタメタゾン添加，
験液からの蘇酔田復
















73. 7 :t 








20.2土11.2 :t 4.8 
10.0 こと 4. 1 
L + S 
L + BM + S 65.9土25.6土
L: 2% lidocaine， BM: 0.3% betamethasone， S:0.01 % Na-sa!icy!ate.表中の表示:表3と|可じ.



































AP area after 30min 
(%) 



























土 0.7*1.5 6.8 :t S + + BM 
B: 0.3%以lpivacaine，BM: 0.3% betamethasone， S:0.01 % Na-salicylate.表中の表示:表2と同






























Recovery time Half Recovery time AP area after 30min 
Drugs 
(min) (min) ( %) 
B 2.3 :t 0.5 81. 0 :t 19.3 
B + BM 5.0 3.8土 0.6 77.9土 6.4 
B + S 8.0 :t 2.6* 56.6 :t 3.6キ
B + BM + S 11.2 ごと 4.8 14.4土 4.O' 61. 4土 14.3*
B: 0.3% bupivacaine， BM: 0.3% betamethasone， S:0.01% Na-salicy1ate.表中の表示:表3と同
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